Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
The Lancet Regional Health. Europe|December 3, 2025
Cost-effectiveness of pramipexole augmentation for acute phase and maintenance therapy of treatment-resistant depression compared to placebo augmentation: economic evaluation of the PAX-D randomised controlled trialAgata Łaszewska, Timea Helter, Ashley Baldwin, et al.
Trials|February 14, 2019
The Oxford study of Calcium channel Antagonism, Cognition, Mood instability and Sleep (OxCaMS): study protocol for a randomised controlled, experimental medicine studyLauren Z Atkinson, Lucy Colbourne, Alexander Smith, et al.
The Lancet. Psychiatry|March 20, 2025
Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression: a pragmatic, open-label, parallel-group, randomised controlled superiority trial in the UKAnthony J Cleare, Jess Kerr-Gaffney, Kimberley Goldsmith, et al.
JMIR Mental Health|August 22, 2022
Impact of the COVID-19 Pandemic on the Global Delivery of Mental Health Services and Telemental Health: Systematic ReviewCaroline Zangani, Edoardo G Ostinelli, Katharine A Smith, et al.
BMJ Open|July 13, 2016
Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysisToshi A Furukawa, Georgia Salanti, Lauren Z Atkinson, et al.
The Lancet. Psychiatry|October 4, 2016
Data science for mental health: a UK perspective on a global challengeAndrew M McIntosh, Robert Stewart, Ann John, et al.
Focus (American Psychiatric Publishing)|February 6, 2020
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-AnalysisAndrea Cipriani, Toshi A Furukawa, Georgia Salanti, et al.
Focus (American Psychiatric Publishing)|August 1, 2026
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-AnalysisAndrea Cipriani, Toshi A Furukawa, Georgia Salanti, et al.
Lancet (London, England)|February 26, 2018
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysisAndrea Cipriani, Toshi A Furukawa, Georgia Salanti, et al.
BMJ Open|August 30, 2019
Automated virtual reality (VR) cognitive therapy for patients with psychosis: study protocol for a single-blind parallel group randomised controlled trial (gameChange)Daniel Freeman, Ly-Mee Yu, Thomas Kabir, et al.
Pageof 17